SHMT2 and colorectal carcinoma: To more thoroughly understand the contribution of SHMT2 to the prognosis of patients with CRC, especially its effect on the response to 5-FU–based adjuvant chemotherapy, we investigated the correlation of SHMT2 expression levels with disease-free survival (DFS) and overall survival (OS) in CRC patients.